TriangleNCT00920556 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- other Details
- GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- limitations And Caveats
- description
- The study of Multiple Myeloma, was terminated early due to minimal efficacy signal observed.
- point Of Contact
- organization
- GlaxoSmithKline
- phone
- 866-435-7343
- title
- GSK Response Center
Complete source fields
- certain Agreement
- other Details
- GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- limitations And Caveats
- description
- The study of Multiple Myeloma, was terminated early due to minimal efficacy signal observed.
- point Of Contact
- organization
- GlaxoSmithKline
- phone
- 866-435-7343
- title
- GSK Response Center
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice